SLT-VEGF is highly cytotoxic to VEGFR-2 overexpressing cells in vitro, and selectively depletes such cells in tumor vasculature of autologous mouse 4T1 mammary carcinoma tumors and of human PC3 prostate tumor xenografts. Here, KDR is linked to neoplasm.